Angiographic outcomes assessed by core lab: immediate, 3 months, and 1 year
| Small <10 mm | Large 10–24 mm | Giant >25 mm | |
|---|---|---|---|
| Postembolization occlusion rates | |||
| n = 20 (%) | n = 60 (%) | n = 19 (%) | |
| Complete (100%) | 15 (75) | 33 (55) | 19 (47) |
| Subtotal (90–99%) | 5 (25) | 26 (43) | 19 (47) |
| Incomplete (<90%) | — | 1 (2) | 1 (5) |
| 3–6 month follow-up occlusion rates | |||
| n = 15 (%) | n = 51 (%) | n = 15 (%) | |
| Complete (100%) | 13 (86.7) | 31 (61) | 8 (53) |
| Subtotal (90–99%) | 1 (6.7) | 12 (23) | 4 (27) |
| Incomplete (<90%) | 1 (6.7) | 7 (14) | 2 (13) |
| Not determinable | 1 (2) | 1 (7) | |
| 12-month follow-up occlusion rates | |||
| After re-treatment, when applicable | |||
| n = 14 (%) | n = 39 (%) | n = 14 (%) | |
| Complete (100%) | 13 (93) | 30 (77) | 8 (57) |
| Subtotal (90–99%) | 0 | 5 (13) | 2 (14) |
| Incomplete (<90%) | 1 (7) | 2 (5) | 2 (14) |
| Not determinable | 2 (5) | 2 (14) |